| Literature DB >> 31332584 |
Liling Zeng1, Chen Sun2, Zhong Pei3, Tianchan Yun1, Shaoyi Fan1, Simei Long3, Tengteng Wu3, Ziwen Chen1, Zhimin Yang4, Fuping Xu5.
Abstract
Liangyi Gao (LYG), a traditional Chinese medicine, is composed of Ginseng and Radix Rehmanniae Preparata, both of which have been shown to have antiaging properties. In Eastern countries, LYG is used to delay functional declines related to aging and has an obvious antiaging effect in clinical practice. However, little data from evidence-based medicine is available regarding whether LYG is beneficial overall, particularly with respect to lifespan, and how LYG functions. To address these issues, Caenorhabditis elegans, a useful organism for such studies, was employed to explore the antiaging effect and mechanism of LYG in this study. The results showed that LYG could obviously extend lifespan and slow aging-related declines in N2 wild-type C. elegans. To further characterize these antiaging effects and stress resistance, reproductive tests and other aging-related tests were performed. We found that LYG enhanced resistance against oxidative and thermal stress, reproduction, pharynx pumping, motility and growth in N2 wild-type C. elegans. In addition, we analyzed the mechanism for these effects by measuring the activity of superoxide dismutase (SOD) and the expression levels of aging-related genes. We found that LYG enhanced the activities of antioxidant enzymes and upregulated the genes daf-16, sod-3 and sir-2.1, which mediated stress resistance and longevity. In conclusion, LYG had robust and reproducible life-prolonging and antiaging benefits in C. elegans via DAF-16/FOXO regulation.Entities:
Keywords: Antiaging; Caenorhabditis elegans; DAF-16/FOXO regulation; Liangyi Gao; Traditional Chinese Medicine
Mesh:
Substances:
Year: 2019 PMID: 31332584 PMCID: PMC6733806 DOI: 10.1007/s10522-019-09820-7
Source DB: PubMed Journal: Biogerontology ISSN: 1389-5729 Impact factor: 4.277
The components, dose proportions, and original concentrations of the drugs in the different groups
| Groups and drugs | Components | Dose proportion | Original concentration (mg/ml)a |
|---|---|---|---|
| LYG | 1:2 | 1 mg/ml | |
| Rg1 | Ginsenoside Rg1 | – | 150 µg/ml |
| Catalpol | Catalpol | – | 150 µg/ml |
| Rg1 + Catalpol | Ginsenoside Rg and catalpol | 1:1 | 150 µg/ml |
| Control | DMSO | – | Equal to the other groups |
aThe concentrations of the drugs used to treat N2 wild-type nematodes in this study were determined by a dose–effect curve and were chosen based on the dose with the greatest effect on the lifespan of N2 wild-type nematodes; DMSO, dimethylsulfoxide
Fig. 1Effect on the lifespan and stress resistance in C. elegans N2. a Effect on lifespan extension. b Effect on heat stress resistance. c Effect on oxidative stress resistance
Effect on lifespan extension
| Mean lifespana | Maximum lifespan | Decline in mean lifespan (%)b | ||
|---|---|---|---|---|
| LYG | 19.44 ± 0.80 | 32 | – | – |
| Rg1 | 17.08 ± 0.69 | 28 | 12.1 | 0.03* |
| Catalpol | 16.85 ± 0.57 | 26 | 2.3 | 0.00*** |
| Rg1 + Catalpol | 18.27 ± 0.75 | 30 | 6.0 | 0.29 |
| Control | 15.7 ± 0.64 | 26 | 19.2 | 0.00*** |
aMean lifespan is presented as the mean ± SEM
bDecline in mean lifespan compared with the LYG group (%)
cStatistical significance of the difference between the survival curves was determined by the log-rank test using Kaplan–Meier survival analysis. Differences compared to the LYG group were considered significant at *P < 0.05 and ***P < 0.01
Fig. 2Effects on aging-related factors. a Effect on reproduction. b Effect on body length. c Effect on pharyngeal pumping. d Effect on body movement
Fig. 3Effect on lipofuscin accumulation. a The lipofuscin accumulation was lowest in LYG-treated worms, and the difference compared to the control-treated worms was significant (P < 0.001). b Fluorescence intensity of intestinal lipofuscin in the control worms. c Fluorescence intensity of intestinal lipofuscin in the LYG-fed worms
Fig. 4a Effect of LYG on antioxidant enzyme (SOD) activity. b The fluorescence intensity of SOD-3::GFP expression in LYG-treated CF1553 worms was significantly stronger than that in the worms in the control group. c Fluorescence intensity of SOD-3::GFP expression in LYG-treated CF1553 worms. d Fluorescence intensity of SOD-3::GFP expression in control CF1553 worms
Fig. 5a The quantified relative expression of mRNA. b Effects of heat shock on the nuclear localization of daf-16. c Effects of LYG treatment on the nuclear localization of daf-16. d The control group